LEN
52
2
SRE
54
-3
DVA
76
6
VNO
65
2
HAL
51
-3
SE
41
8
AEE
45
2
RL
69
4
SRCL
50
3
MRK
53
3
CHD
64
2
TJX
61
3
AES
40
-5
FRT
53
3
PDCO
60
13
GRMN
58
3
EMR
51
11
URBN
66
4
IFF
48
4
PAYX
50
5
LEN
52
2
SRE
54
-3
DVA
76
6
VNO
65
2
HAL
51
-3
SE
41
8
AEE
45
2
RL
69
4
SRCL
50
3
MRK
53
3
CHD
64
2
TJX
61
3
AES
40
-5
FRT
53
3
PDCO
60
13
GRMN
58
3
EMR
51
11
URBN
66
4
IFF
48
4
PAYX
50
5
Financhill
Back

Fate Therapeutics Stock Price Chart

BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty

Click here now to prepare yourself for what's around the corner
Sell
27

FATE
Fate Therapeutics

Last Price:
4.55
Seasonality Move:
0.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Master the Market: The Formula for a 96.3% Win Rate Revealed!

Act now!
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FATE is experiencing slight selling pressure.

Fate Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 5.33 Sell
20-day SMA: 6.28 Sell
50-day SMA: 6.84 Sell
200-day SMA: 4.09 Buy
8-day EMA: 5.34 Sell
20-day EMA: 6.01 Sell
50-day EMA: 6.23 Sell
200-day EMA: 5.84 Sell

Fate Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 25.4 Sell
Chaikin Money Flow: -32107 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.61 - 7.29) Sell
Bollinger Bands (100): (3.65 - 7.19) Sell

Fate Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Fate Therapeutics Stock

Is Fate Therapeutics Stock a Buy?

  • Fate Therapeutics share price is 4.79 while FATE 8-day simple moving average is 5.33, which is a Sell signal.
  • The stock price of FATE is 4.79 while Fate Therapeutics 20-day SMA is 6.28, which makes it a Sell.
  • Fate Therapeutics 50-day simple moving average is 6.84 while FATE share price is 4.79, making it a Sell technically.
  • FATE stock price is 4.79 and Fate Therapeutics 200-day simple moving average is 4.09, creating a Buy signal.

FATE Technical Analysis vs Fundamental Analysis

Sell
27
Fate Therapeutics (FATE) is a Sell

Is Fate Therapeutics a Buy or a Sell?

  • Fate Therapeutics stock is rated a Sell
    The current Fate Therapeutics [FATE] share price is $4.79. The Score for FATE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.

Fate Therapeutics Stock Info

Market Cap:
475.25M
Price in USD:
4.79
Share Volume:
1.17M

Fate Therapeutics 52-Week Range

52-Week High:
8.83
52-Week Low:
1.63
Sell
27
Fate Therapeutics (FATE) is a Sell

Fate Therapeutics Share Price Forecast

Is Fate Therapeutics Stock a Buy?

  • Fate Therapeutics share price is 4.79 while FATE 8-day exponential moving average is 5.34, which is a Sell signal.
  • The stock price of FATE is 4.79 while Fate Therapeutics 20-day EMA is 6.01, which makes it a Sell.
  • Fate Therapeutics 50-day exponential moving average is 6.23 while FATE share price is 4.79, making it a Sell technically.
  • FATE stock price is 4.79 and Fate Therapeutics 200-day simple moving average is 5.84, creating a Sell signal.

Fundamental Analysis of Fate Therapeutics

Is Fate Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.15 per share, and an increase next year of $0.20 per share.

Technical Analysis of Fate Therapeutics

Should I short Fate Therapeutics stock?

* Fate Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.